​

Insight Molecular Diagnostics Ownership | Who Owns Insight Molecular Diagnostics?


OverviewForecastRevenueFinancialsChartTranscripts

Insight Molecular Diagnostics Ownership Summary


Insight Molecular Diagnostics is owned by 47.98% institutional investors, 21.00% insiders, and 31.02% retail investors. Broadwood capital is the largest institutional shareholder, holding 34.52% of IMDX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.47% of its assets in Insight Molecular Diagnostics shares.

IMDX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInsight Molecular Diagnostics47.98%21.00%31.02%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryDiagnostics & Research Stocks87.01%9.51%3.48%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Broadwood capital12.68M34.52%$45.54M
Awm investment company2.77M7.54%$9.95M
Pura vida investments947.13K3.11%$3.11M
Vanguard capital management731.39K1.99%$2.63M
Fny investment advisers247.42K0.81%$811.00K
Geode capital management270.56K0.74%$972.06K
Family office research127.27K0.42%$417.43K
Vanguard fiduciary trust150.92K0.41%$541.80K
Blackrock funding, inc. /de148.53K0.40%$533.21K
Millennium management103.47K0.34%$339.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pura vida investments947.13K20.88%$3.11M
Broadwood capital12.68M2.92%$45.54M
Awm investment company2.77M0.96%$9.95M
Fny investment advisers247.42K0.35%$811.00K
Family office research127.27K0.18%$417.43K
Flatrock wealth partners14.30K0.02%$51.34K
Transce3nd1.00K0.00%$3.02K
Smith, moore10.00K0.00%$35.90K
Xtx topco30.35K0.00%$99.56K
Savvy advisors15.00K0.00%$53.85K

Top Buyers

HolderShares% AssetsChange
Fny investment advisers247.42K0.35%206.84K
Family office research127.27K0.18%127.27K
Walleye capital57.59K0.00%57.59K
Millennium management103.47K0.00%42.09K
Jump financial35.40K0.00%35.40K

Top Sellers

HolderShares% AssetsChange
Alyeska investment group---840.78K
Heights capital management---392.55K
Jane street group36.08K--121.60K
Ghisallo capital management---70.69K
Awm investment company2.77M0.96%-64.93K

New Positions

HolderShares% AssetsChangeValue
Family office research127.27K0.18%127.27K$417.43K
Walleye capital57.59K0.00%57.59K$206.74K
Jump financial35.40K0.00%35.40K$127.09K
Xtx topco30.35K0.00%30.35K$99.56K
Savvy advisors15.00K0.00%15.00K$53.85K

Sold Out

HolderChange
Global retirement partners-1.00
Federation des caisses desjardins du quebec-1.00
Cassaday & co wealth management-6.00
Tower research capital llc (trc)-250.00
Citigroup-815.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202638-7.32%17,632,156-4.51%471.90%23-7-12.50%
Jun 30, 202641-18,464,414-2.50%501.67%23-14.81%833.33%
Mar 31, 202620-41.18%2,180,616-86.90%70.26%14-12.50%--100.00%
Dec 31, 20253425.93%16,651,6002.26%512.01%1677.78%7-
Sep 30, 202527-10.00%16,282,8846.65%502.24%9-43.75%716.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv475.40K1.47%-
Vanguard Morn Total Stk Mkt Idx Investor475.40K1.47%-
Vanguard MStar Total Stk Mkt Idx Invest475.40K1.45%-
Vanguard Institutional Extnd Mkt Idx Tr248.06K0.76%-
Fidelity Extended Market Index124.03K0.38%16.59K
Extended Equity Market Fund E54.35K0.17%43.70K
Blackrock Extended Mkt Fund CF54.35K0.17%-
Extended Equity Market Fund B54.35K0.17%43.70K
BlackRock Extended Equity Market Fund K46.19K0.14%-85.00
iShares Micro-Cap ETF39.27K0.12%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 17, 2026BROADWOOD PARTNERS, L.P.-Buy-
Nov 17, 2026BROADWOOD PARTNERS, L.P.-Buy$6.00M
Apr 24, 2026BROADWOOD PARTNERS, L.P.-Buy-
Apr 27, 2026BROADWOOD PARTNERS, L.P.-Buy-
Apr 27, 2026BROADWOOD PARTNERS, L.P.-Buy$913.13K

Insider Transactions Trends


DateBuySell
2026 Q42-
2026 Q3--
2026 Q212-
2026 Q12-
2025 Q4--

IMDX Ownership FAQ


Who Owns Insight Molecular Diagnostics?

Insight Molecular Diagnostics shareholders are primarily institutional investors at 47.98%, followed by 21.00% insiders and 31.02% retail investors. The average institutional ownership in Insight Molecular Diagnostics's industry, Diagnostics & Research Stocks, is 87.01%, which Insight Molecular Diagnostics falls below.

Who owns the most shares of Insight Molecular Diagnostics?

Insight Molecular Diagnostics’s largest shareholders are Broadwood capital (12.68M shares, 34.52%), Awm investment company (2.77M shares, 7.54%), and Pura vida investments (947.13K shares, 3.11%). Together, they hold 45.17% of Insight Molecular Diagnostics’s total shares outstanding.

Does Blackrock own Insight Molecular Diagnostics?

BlackRock is not among the top 10 institutional shareholders of Insight Molecular Diagnostics.

Who is Insight Molecular Diagnostics’s biggest shareholder by percentage of total assets invested?

Pura vida investments is Insight Molecular Diagnostics’s biggest shareholder by percentage of total assets invested, with 20.88% of its assets in 947.13K Insight Molecular Diagnostics shares, valued at 3.11M$.

Who is the top mutual fund holder of Insight Molecular Diagnostics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Insight Molecular Diagnostics shares, with 1.47% of its total shares outstanding invested in 475.4K Insight Molecular Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools